This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Regents of the University of Minnesota, Shire Human Genetic Therapies, Inc.. Active years: 2018.
Company Filing History:
1 out of 2,367 
1 out of 86 
Years Active: 2018
Title: The Innovative Contributions of Thomas M. Luby
Introduction
Thomas M. Luby, an accomplished inventor based in Lexington, Massachusetts, has made significant contributions to the field of biotechnology with his groundbreaking research. With a singular patent to his name, Luby focuses on innovative treatments for Duchenne muscular dystrophy (DMD), a condition that impacts countless individuals worldwide.
Latest Patents
Luby's notable patent, titled "Anti-FLT-1 antibodies in treating Duchenne muscular dystrophy," presents methods and compositions aimed at addressing the challenges associated with DMD. The invention details a method that involves administering an effective amount of an anti-Flt-1 antibody, or an antigen-binding fragment thereof, to individuals affected by the disease. This approach aims to reduce the intensity, severity, or frequency of symptoms or features associated with DMD, or potentially delay its onset.
Career Highlights
Throughout his career, Thomas M. Luby has been associated with reputable organizations, including Shire Human Genetic Therapies, Inc. and the University of Minnesota. His work in these institutions has contributed to advancements in genetic therapies and has positioned him as a knowledgeable figure in the field of muscular dystrophy treatment.
Collaborations
In his pursuit of innovation, Luby has collaborated with esteemed colleagues such as Serene Josiah and Atsushi Asakura. These collaborations have likely enhanced his research efforts and broadened the impact of his work in treating DMD.
Conclusion
Thomas M. Luby's patent and career demonstrate his dedication to addressing serious medical conditions through innovative science. His work with anti-FLT-1 antibodies represents a promising avenue for treatment options for individuals suffering from Duchenne muscular dystrophy, showcasing the critical role inventors play in advancing healthcare solutions.